Status:
UNKNOWN
Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
Lead Sponsor:
Qingdao University
Conditions:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Eligibility:
All Genders
3-35 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for initial type 1 diabetes is safe and effective.
Detailed Description
Type 1 diabetes mellitus (T1DM)is characterized by the autoimmune destruction of the pancreatic β cells.Patients require multiple daily insulin injections throughout their lives as well as close monit...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of type 1 diabetes by ADA criteria less than 9 weeks.
- Ability to provide written informed consent from patients or Child guardian.
Exclusion
- diabetic ketoacidosis.
- evidence of retinopathy at baseline.
- Body Mass Index \>30.
- Severe or acute organ damage.
- Infectious diseases, e.g. HIV infection, or hepatitis B or C infection.
- Severe psychiatric disorder.
- Presence of malignancy.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01219465
Start Date
September 1 2010
End Date
December 1 2012
Last Update
October 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stem Cell Research Center of Medical School Hospital of Qingdao University
Qingdao, Shandong, China, 266003